257 related articles for article (PubMed ID: 15929329)
1. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
Hansen ML; Rumessen JJ
Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
[No Abstract] [Full Text] [Related]
2. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
Cho YW; Aviado DM
J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
[No Abstract] [Full Text] [Related]
3. Pancreatic enzyme pharmacotherapy.
Ferrone M; Raimondo M; Scolapio JS
Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
[TBL] [Abstract][Full Text] [Related]
4. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
[No Abstract] [Full Text] [Related]
5. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
Dutta SK; Tilley DK
J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
[No Abstract] [Full Text] [Related]
6. Theory and practice in the individualization of oral pancreatic enzyme administration for chronic pancreatitis.
Andrén-Sandberg A
Int J Pancreatol; 1989; 5 Suppl():51-62. PubMed ID: 2702251
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic enzyme supplement dosage in cystic fibrosis.
Owen G; Peters TJ; Dawson S; Goodchild MC
Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
[No Abstract] [Full Text] [Related]
8. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Zsíros J; Sólyom E
Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
[No Abstract] [Full Text] [Related]
10. Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis.
Kalnins D; Corey M; Ellis L; Durie PR; Pencharz PB
J Pediatr; 2005 Apr; 146(4):489-93. PubMed ID: 15812451
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
[TBL] [Abstract][Full Text] [Related]
12. [Enzyme preparations in conservative treatment of chronic pancreatitis].
Okhlobystin AV; Bayarmaa N
Ter Arkh; 1998; 70(10):86-8. PubMed ID: 9864814
[TBL] [Abstract][Full Text] [Related]
13. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis.
Brown A; Hughes M; Tenner S; Banks PA
Am J Gastroenterol; 1997 Nov; 92(11):2032-5. PubMed ID: 9362186
[TBL] [Abstract][Full Text] [Related]
14. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
16. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
Löser C; Fölsch UR
Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic enzyme replacement therapy in post-pancreatectomy patients.
Braga M; Cristallo M; De Franchis R; Mangiagalli A; Zerbi A; Agape D; Primignani M; Di Carlo V
Int J Pancreatol; 1989; 5 Suppl():37-44. PubMed ID: 2702249
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
[TBL] [Abstract][Full Text] [Related]
20. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
Vyas H; Matthew DJ; Milla PJ
Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
